Global Nitric Oxide Therapy System Market Analysis and Forecast 2024-2030

Global Nitric Oxide Therapy System Market Analysis and Forecast 2024-2030


Summary

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

According to APO Research, The global Nitric Oxide Therapy System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nitric Oxide Therapy System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Nitric Oxide Therapy System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Nitric Oxide Therapy System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Nitric Oxide Therapy System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Nitric Oxide Therapy System include Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals and Praxair,, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nitric Oxide Therapy System, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Nitric Oxide Therapy System, also provides the revenue of main regions and countries. Of the upcoming market potential for Nitric Oxide Therapy System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nitric Oxide Therapy System revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nitric Oxide Therapy System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Nitric Oxide Therapy System revenue, projected growth trends, production technology, application and end-user industry.

Nitric Oxide Therapy System segment by Company

Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Nitric Oxide Therapy System segment by Type

Protable System
Fixed System
Nitric Oxide Therapy System segment by Application

Hospitals
Homecare Settings
Others
Nitric Oxide Therapy System segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitric Oxide Therapy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitric Oxide Therapy System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitric Oxide Therapy System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Nitric Oxide Therapy System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Nitric Oxide Therapy System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitric Oxide Therapy System revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Nitric Oxide Therapy System Market by Type
1.2.1 Global Nitric Oxide Therapy System Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Protable System
1.2.3 Fixed System
1.3 Nitric Oxide Therapy System Market by Application
1.3.1 Global Nitric Oxide Therapy System Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Nitric Oxide Therapy System Market Dynamics
2.1 Nitric Oxide Therapy System Industry Trends
2.2 Nitric Oxide Therapy System Industry Drivers
2.3 Nitric Oxide Therapy System Industry Opportunities and Challenges
2.4 Nitric Oxide Therapy System Industry Restraints
3 Global Growth Perspective
3.1 Global Nitric Oxide Therapy System Market Perspective (2019-2030)
3.2 Global Nitric Oxide Therapy System Growth Trends by Region
3.2.1 Global Nitric Oxide Therapy System Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Nitric Oxide Therapy System Market Size by Region (2019-2024)
3.2.3 Global Nitric Oxide Therapy System Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Nitric Oxide Therapy System Revenue by Players
4.1.1 Global Nitric Oxide Therapy System Revenue by Players (2019-2024)
4.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Players (2019-2024)
4.1.3 Global Nitric Oxide Therapy System Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Nitric Oxide Therapy System Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Nitric Oxide Therapy System Key Players Headquarters & Area Served
4.4 Global Nitric Oxide Therapy System Players, Product Type & Application
4.5 Global Nitric Oxide Therapy System Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Nitric Oxide Therapy System Market CR5 and HHI
4.6.2 Global Top 5 and 10 Nitric Oxide Therapy System Players Market Share by Revenue in 2023
4.6.3 2023 Nitric Oxide Therapy System Tier 1, Tier 2, and Tier 3
5 Nitric Oxide Therapy System Market Size by Type
5.1 Global Nitric Oxide Therapy System Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Nitric Oxide Therapy System Revenue by Type (2019-2030)
5.3 Global Nitric Oxide Therapy System Revenue Market Share by Type (2019-2030)
6 Nitric Oxide Therapy System Market Size by Application
6.1 Global Nitric Oxide Therapy System Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Nitric Oxide Therapy System Revenue by Application (2019-2030)
6.3 Global Nitric Oxide Therapy System Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Bellerophon Therapeutics
7.1.1 Bellerophon Therapeutics Comapny Information
7.1.2 Bellerophon Therapeutics Business Overview
7.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio
7.1.5 Bellerophon Therapeutics Recent Developments
7.2 BOC Healthcare
7.2.1 BOC Healthcare Comapny Information
7.2.2 BOC Healthcare Business Overview
7.2.3 BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.2.4 BOC Healthcare Nitric Oxide Therapy System Product Portfolio
7.2.5 BOC Healthcare Recent Developments
7.3 Dan Hammer Health
7.3.1 Dan Hammer Health Comapny Information
7.3.2 Dan Hammer Health Business Overview
7.3.3 Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.3.4 Dan Hammer Health Nitric Oxide Therapy System Product Portfolio
7.3.5 Dan Hammer Health Recent Developments
7.4 EKU Elektronik GmbH
7.4.1 EKU Elektronik GmbH Comapny Information
7.4.2 EKU Elektronik GmbH Business Overview
7.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio
7.4.5 EKU Elektronik GmbH Recent Developments
7.5 GeNO LLC
7.5.1 GeNO LLC Comapny Information
7.5.2 GeNO LLC Business Overview
7.5.3 GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.5.4 GeNO LLC Nitric Oxide Therapy System Product Portfolio
7.5.5 GeNO LLC Recent Developments
7.6 International Biomedical
7.6.1 International Biomedical Comapny Information
7.6.2 International Biomedical Business Overview
7.6.3 International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.6.4 International Biomedical Nitric Oxide Therapy System Product Portfolio
7.6.5 International Biomedical Recent Developments
7.7 SLE
7.7.1 SLE Comapny Information
7.7.2 SLE Business Overview
7.7.3 SLE Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.7.4 SLE Nitric Oxide Therapy System Product Portfolio
7.7.5 SLE Recent Developments
7.8 Mallinckrodt Pharmaceuticals
7.8.1 Mallinckrodt Pharmaceuticals Comapny Information
7.8.2 Mallinckrodt Pharmaceuticals Business Overview
7.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio
7.8.5 Mallinckrodt Pharmaceuticals Recent Developments
7.9 Praxair,
7.9.1 Praxair, Comapny Information
7.9.2 Praxair, Business Overview
7.9.3 Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.9.4 Praxair, Nitric Oxide Therapy System Product Portfolio
7.9.5 Praxair, Recent Developments
7.10 Vapotherm
7.10.1 Vapotherm Comapny Information
7.10.2 Vapotherm Business Overview
7.10.3 Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.10.4 Vapotherm Nitric Oxide Therapy System Product Portfolio
7.10.5 Vapotherm Recent Developments
7.11 Linde Group
7.11.1 Linde Group Comapny Information
7.11.2 Linde Group Business Overview
7.11.3 Linde Group Nitric Oxide Therapy System Revenue and Gross Margin (2019-2024)
7.11.4 Linde Group Nitric Oxide Therapy System Product Portfolio
7.11.5 Linde Group Recent Developments
8 North America
8.1 North America Nitric Oxide Therapy System Revenue (2019-2030)
8.2 North America Nitric Oxide Therapy System Revenue by Type (2019-2030)
8.2.1 North America Nitric Oxide Therapy System Revenue by Type (2019-2024)
8.2.2 North America Nitric Oxide Therapy System Revenue by Type (2025-2030)
8.3 North America Nitric Oxide Therapy System Revenue Share by Type (2019-2030)
8.4 North America Nitric Oxide Therapy System Revenue by Application (2019-2030)
8.4.1 North America Nitric Oxide Therapy System Revenue by Application (2019-2024)
8.4.2 North America Nitric Oxide Therapy System Revenue by Application (2025-2030)
8.5 North America Nitric Oxide Therapy System Revenue Share by Application (2019-2030)
8.6 North America Nitric Oxide Therapy System Revenue by Country
8.6.1 North America Nitric Oxide Therapy System Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Nitric Oxide Therapy System Revenue by Country (2019-2024)
8.6.3 North America Nitric Oxide Therapy System Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Nitric Oxide Therapy System Revenue (2019-2030)
9.2 Europe Nitric Oxide Therapy System Revenue by Type (2019-2030)
9.2.1 Europe Nitric Oxide Therapy System Revenue by Type (2019-2024)
9.2.2 Europe Nitric Oxide Therapy System Revenue by Type (2025-2030)
9.3 Europe Nitric Oxide Therapy System Revenue Share by Type (2019-2030)
9.4 Europe Nitric Oxide Therapy System Revenue by Application (2019-2030)
9.4.1 Europe Nitric Oxide Therapy System Revenue by Application (2019-2024)
9.4.2 Europe Nitric Oxide Therapy System Revenue by Application (2025-2030)
9.5 Europe Nitric Oxide Therapy System Revenue Share by Application (2019-2030)
9.6 Europe Nitric Oxide Therapy System Revenue by Country
9.6.1 Europe Nitric Oxide Therapy System Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Nitric Oxide Therapy System Revenue by Country (2019-2024)
9.6.3 Europe Nitric Oxide Therapy System Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Nitric Oxide Therapy System Revenue (2019-2030)
10.2 China Nitric Oxide Therapy System Revenue by Type (2019-2030)
10.2.1 China Nitric Oxide Therapy System Revenue by Type (2019-2024)
10.2.2 China Nitric Oxide Therapy System Revenue by Type (2025-2030)
10.3 China Nitric Oxide Therapy System Revenue Share by Type (2019-2030)
10.4 China Nitric Oxide Therapy System Revenue by Application (2019-2030)
10.4.1 China Nitric Oxide Therapy System Revenue by Application (2019-2024)
10.4.2 China Nitric Oxide Therapy System Revenue by Application (2025-2030)
10.5 China Nitric Oxide Therapy System Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Nitric Oxide Therapy System Revenue (2019-2030)
11.2 Asia Nitric Oxide Therapy System Revenue by Type (2019-2030)
11.2.1 Asia Nitric Oxide Therapy System Revenue by Type (2019-2024)
11.2.2 Asia Nitric Oxide Therapy System Revenue by Type (2025-2030)
11.3 Asia Nitric Oxide Therapy System Revenue Share by Type (2019-2030)
11.4 Asia Nitric Oxide Therapy System Revenue by Application (2019-2030)
11.4.1 Asia Nitric Oxide Therapy System Revenue by Application (2019-2024)
11.4.2 Asia Nitric Oxide Therapy System Revenue by Application (2025-2030)
11.5 Asia Nitric Oxide Therapy System Revenue Share by Application (2019-2030)
11.6 Asia Nitric Oxide Therapy System Revenue by Country
11.6.1 Asia Nitric Oxide Therapy System Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Nitric Oxide Therapy System Revenue by Country (2019-2024)
11.6.3 Asia Nitric Oxide Therapy System Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Nitric Oxide Therapy System Revenue (2019-2030)
12.2 MEALA Nitric Oxide Therapy System Revenue by Type (2019-2030)
12.2.1 MEALA Nitric Oxide Therapy System Revenue by Type (2019-2024)
12.2.2 MEALA Nitric Oxide Therapy System Revenue by Type (2025-2030)
12.3 MEALA Nitric Oxide Therapy System Revenue Share by Type (2019-2030)
12.4 MEALA Nitric Oxide Therapy System Revenue by Application (2019-2030)
12.4.1 MEALA Nitric Oxide Therapy System Revenue by Application (2019-2024)
12.4.2 MEALA Nitric Oxide Therapy System Revenue by Application (2025-2030)
12.5 MEALA Nitric Oxide Therapy System Revenue Share by Application (2019-2030)
12.6 MEALA Nitric Oxide Therapy System Revenue by Country
12.6.1 MEALA Nitric Oxide Therapy System Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Nitric Oxide Therapy System Revenue by Country (2019-2024)
12.6.3 MEALA Nitric Oxide Therapy System Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings